Market Cap 10.24M
Revenue (ttm) 43.95M
Net Income (ttm) -43.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -98.98%
Debt to Equity Ratio 0.00
Volume 147,700
Avg Vol 112,680
Day's Range N/A - N/A
Shares Out 12.19M
Stochastic %K 50%
Beta 0.93
Analysts Hold
Price Target $2.00

Company Profile

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of...

Industry: Biotechnology
Sector: Healthcare
Phone: 431 890 6360
Address:
350 Fifth Avenue, 72nd Floor Suite 7240, New York, United States
TheRealShortSqueezy
TheRealShortSqueezy Apr. 16 at 4:14 PM
$CELZ: Bullish Momentum Building After Prolonged Base Formation 📡🧬 Recent price action reflects tight consolidation, with buyers stepping in on dips and volume beginning to expand, suggesting early stage interest returning. Technical View: 🔹 Prolonged downtrend transitioning into sideways base 🔹 Higher lows forming within consolidation structure 🔹 Compression beneath resistance = potential breakout setup Key Levels to Watch: 🎯 $2.02 🟰 Key support / reclaim level 🎯 $2.35–$2.51 🟰 Near-term resistance zone 🎯 $2.74 🟰 Breakout confirmation level 🎯 $3.08–$3.34 🟰 Major supply area It will be interesting to keep on watch management next business update and press releases. Their data results could increase shareholder value significantly Communicated Disclaimer: http://tinyurl.com/Therealshortsq… Sector Peers: $VXRT $HOOK $BCDA $CAPR
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Apr. 16 at 1:42 PM
🧬 $CELZ : A Tiny Biotech Taking a Shot at Huge Markets Creative Medical Technology Holdings is a regenerative medicine company developing stem cell therapies aimed at treating chronic pain, diabetes, and immune disorders by targeting disease at the source. Recent Milestones ✔️ Completed patient enrollment in the Phase 2 ADAPT trial for chronic lower back pain ✔️ Reported strong interim data with high response rates and improved function ✔️ Achieved second WHO International Nonproprietary Name milestone (Feb 2026), now with dual programs recognized globally Catalysts to Watch 🗓️ Full Phase 2 ADAPT data readout expected in 2026 🗓️ Potential follow up trial design or FDA discussions after data release 🗓️ Potential partnership or licensing activity as clinical data matures With clinical data emerging and multiple programs in play, CELZ is going after $100B+ markets. Communicated Disclaimer: https://tinyurl.com/TherealshortsqueezyCELZ Sector Peers: $VXRT $HOOK $ATOS $CLRB
0 · Reply
joe77w
joe77w Apr. 3 at 2:10 PM
$HOOK 2025 ANNUAL REPORT OUT, LINK https://www.otcmarkets.com/file/company/financial-report/547261/content
0 · Reply
joe77w
joe77w Apr. 3 at 2:09 PM
$HOOK free money here, absurd undervaluation or am I wrong? How Is It possible co to liquidate 1.28/1.71 USD when updated cash position/net equity do imply + 2 USD per shareholder even assuming liquidation and dissolution costs, potential indeminifications and tax liabilities? https://www.otcmarkets.com/file/company/financial-report/547261/content Take a look at balance sheets, 32 mln USD in net equity as of december 31 + 5 mln USD from GILD + 5 mln USD from NEOTRAIL, should have raised net equity/cash available for distribution. Certificate of Dissolution should be filed in late april/early May, then stock delisted from OTC because transfer agent will close books. Am I wrong or market Is underestimating future cash proceeds? NeoTrail bought asset for 5 mln USD, amount disclosed in the last sec filing, GILEAD completed 10 mln USD deal buying every agreed cent. I am assuming +- 14 mln fully diluted common shares. What Is wrong or am I right assuming liquidation North of 2 USD?
0 · Reply
koditrump
koditrump Feb. 10 at 10:43 PM
0 · Reply
biovaluable
biovaluable Feb. 9 at 2:29 AM
$BCAB $BCAB $HOOK oh my god such a fuxx company!
0 · Reply
joe77w
joe77w Feb. 7 at 6:41 PM
$HOOK https://www.otcmarkets.com/filing/html?id=18596713&guid=Aqt-keox_0xjJth
0 · Reply
joe77w
joe77w Feb. 7 at 6:41 PM
$HOOK https://www.otcmarkets.com/file/company/financial-report/507979/content 30 mln in net equity as of September 30 with 12.2 mln shares would be worth 2.45 USD per share in book value. Then we should Add 7.4 mln USD net by GILEAD for assets purchase plus recents asset sale to Neotrail for undisclosed amount. I assume Dissolution and liquidation costs plus some cash burn should be around 12 mln USD with 25 mln USD left to be liquidated to shareholders when and If certificate of Dissolution filed to Delaware SOS... 25 mln /12.2 shares gives me more than 2 USD per share but according most recent meeting to vote Dissolution liquidation value beetwen 1.28 and 1.72 USD per share, what Is wrong? I would assume 1.72 at least if not more... What if bod decides not to file for Dissolution but seeking a merger , there Is a small chance Dissolution cancelled and operations to resume. I find stock very cheap, a Shell with cash and equity without debt or positive equity around 25/30 mln
0 · Reply
dinnerwithme
dinnerwithme Feb. 6 at 4:47 AM
$BCAB $BCAB The company's strategy for maintaining its listing has never been successful. Fact check! 1. Maintain MVLS -> Failure (Nasdaq Disapproval) 2. BP partnership -> Failure (only inversagen AI deal) 3. bid compliance -> Failure (until 2/2) 4. PPA induces high stock conversion(11/26) -> failure, Yorkville maybe exit at Dec, Jan. 5. Issuance of Super Voting Rights -> Failure (Nasdaq Disapproval) 6. RS Strategy -> Failed twice 7. cash -> burning state 8. equity -> Only numbers are resolved through a joint venture from a company related to the representative(invergagen AI). deposit is unknown or secured) 9. Reverse merger -> ???? maybe f..... All that remains is liquidation or delisting. However, after liquidation, the cost for liquidation of creditors and executives and employees comes first. There is no shareholder's share. like $HOOK
0 · Reply
joe77w
joe77w Feb. 6 at 2:39 AM
$HOOK I would expect liquidation to happen at higher range around 1,71 USD given co.completed asset sale to GILEAD and now NEOTRAIL, its a matter of patience. I dont see any downside but only upside, strange pps does not hit 1,28 USD the minimum liquidation value. Holding tight my shares. Do your due diligence before investing your Money. This Is not a financial advice.
0 · Reply
Latest News on HOOK
HOOKIPA Pharma Inc - FORM 8 (OPD)

Jan 8, 2025, 11:23 AM EST - 1 year ago

HOOKIPA Pharma Inc - FORM 8 (OPD)


HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker

Nov 11, 2024, 4:05 PM EST - 1 year ago

HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker


HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

Sep 24, 2024, 7:30 AM EDT - 1 year ago

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset


HOOKIPA Pharma Announces Board of Directors Changes

Aug 30, 2024, 8:00 AM EDT - 1 year ago

HOOKIPA Pharma Announces Board of Directors Changes


HOOKIPA Pharma Transcript: AGM 2024

Jun 17, 2024, 10:00 AM EDT - 2 years ago

HOOKIPA Pharma Transcript: AGM 2024


HOOKIPA Pharma Transcript: Status Update

Jun 4, 2024, 4:15 PM EDT - 2 years ago

HOOKIPA Pharma Transcript: Status Update


HOOKIPA Pharma Transcript: Study Update

Apr 25, 2024, 8:00 AM EDT - 2 years ago

HOOKIPA Pharma Transcript: Study Update


HOOKIPA Announces Executive Leadership Change

Sep 13, 2023, 8:45 AM EDT - 2 years ago

HOOKIPA Announces Executive Leadership Change


HOOKIPA Pharma Transcript: Study Update

Jun 1, 2023, 8:00 AM EDT - 3 years ago

HOOKIPA Pharma Transcript: Study Update


HOOKIPA Pharma Earnings Call Transcript: Q4 2022

Mar 15, 2023, 8:30 AM EDT - 3 years ago

HOOKIPA Pharma Earnings Call Transcript: Q4 2022


HOOKIPA Pharma Transcript: Data Update

Nov 9, 2021, 4:30 PM EST - 4 years ago

HOOKIPA Pharma Transcript: Data Update


HOOKIPA Pharma Transcript: Status Update

Jun 7, 2021, 6:30 PM EDT - 5 years ago

HOOKIPA Pharma Transcript: Status Update


HOOKIPA Pharma Transcript: AGM 2021

Jun 1, 2021, 9:00 AM EDT - 5 years ago

HOOKIPA Pharma Transcript: AGM 2021


HOOKIPA Pharma Transcript: Study Update

Dec 7, 2020, 8:30 AM EST - 5 years ago

HOOKIPA Pharma Transcript: Study Update


TheRealShortSqueezy
TheRealShortSqueezy Apr. 16 at 4:14 PM
$CELZ: Bullish Momentum Building After Prolonged Base Formation 📡🧬 Recent price action reflects tight consolidation, with buyers stepping in on dips and volume beginning to expand, suggesting early stage interest returning. Technical View: 🔹 Prolonged downtrend transitioning into sideways base 🔹 Higher lows forming within consolidation structure 🔹 Compression beneath resistance = potential breakout setup Key Levels to Watch: 🎯 $2.02 🟰 Key support / reclaim level 🎯 $2.35–$2.51 🟰 Near-term resistance zone 🎯 $2.74 🟰 Breakout confirmation level 🎯 $3.08–$3.34 🟰 Major supply area It will be interesting to keep on watch management next business update and press releases. Their data results could increase shareholder value significantly Communicated Disclaimer: http://tinyurl.com/Therealshortsq… Sector Peers: $VXRT $HOOK $BCDA $CAPR
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Apr. 16 at 1:42 PM
🧬 $CELZ : A Tiny Biotech Taking a Shot at Huge Markets Creative Medical Technology Holdings is a regenerative medicine company developing stem cell therapies aimed at treating chronic pain, diabetes, and immune disorders by targeting disease at the source. Recent Milestones ✔️ Completed patient enrollment in the Phase 2 ADAPT trial for chronic lower back pain ✔️ Reported strong interim data with high response rates and improved function ✔️ Achieved second WHO International Nonproprietary Name milestone (Feb 2026), now with dual programs recognized globally Catalysts to Watch 🗓️ Full Phase 2 ADAPT data readout expected in 2026 🗓️ Potential follow up trial design or FDA discussions after data release 🗓️ Potential partnership or licensing activity as clinical data matures With clinical data emerging and multiple programs in play, CELZ is going after $100B+ markets. Communicated Disclaimer: https://tinyurl.com/TherealshortsqueezyCELZ Sector Peers: $VXRT $HOOK $ATOS $CLRB
0 · Reply
joe77w
joe77w Apr. 3 at 2:10 PM
$HOOK 2025 ANNUAL REPORT OUT, LINK https://www.otcmarkets.com/file/company/financial-report/547261/content
0 · Reply
joe77w
joe77w Apr. 3 at 2:09 PM
$HOOK free money here, absurd undervaluation or am I wrong? How Is It possible co to liquidate 1.28/1.71 USD when updated cash position/net equity do imply + 2 USD per shareholder even assuming liquidation and dissolution costs, potential indeminifications and tax liabilities? https://www.otcmarkets.com/file/company/financial-report/547261/content Take a look at balance sheets, 32 mln USD in net equity as of december 31 + 5 mln USD from GILD + 5 mln USD from NEOTRAIL, should have raised net equity/cash available for distribution. Certificate of Dissolution should be filed in late april/early May, then stock delisted from OTC because transfer agent will close books. Am I wrong or market Is underestimating future cash proceeds? NeoTrail bought asset for 5 mln USD, amount disclosed in the last sec filing, GILEAD completed 10 mln USD deal buying every agreed cent. I am assuming +- 14 mln fully diluted common shares. What Is wrong or am I right assuming liquidation North of 2 USD?
0 · Reply
koditrump
koditrump Feb. 10 at 10:43 PM
0 · Reply
biovaluable
biovaluable Feb. 9 at 2:29 AM
$BCAB $BCAB $HOOK oh my god such a fuxx company!
0 · Reply
joe77w
joe77w Feb. 7 at 6:41 PM
$HOOK https://www.otcmarkets.com/filing/html?id=18596713&guid=Aqt-keox_0xjJth
0 · Reply
joe77w
joe77w Feb. 7 at 6:41 PM
$HOOK https://www.otcmarkets.com/file/company/financial-report/507979/content 30 mln in net equity as of September 30 with 12.2 mln shares would be worth 2.45 USD per share in book value. Then we should Add 7.4 mln USD net by GILEAD for assets purchase plus recents asset sale to Neotrail for undisclosed amount. I assume Dissolution and liquidation costs plus some cash burn should be around 12 mln USD with 25 mln USD left to be liquidated to shareholders when and If certificate of Dissolution filed to Delaware SOS... 25 mln /12.2 shares gives me more than 2 USD per share but according most recent meeting to vote Dissolution liquidation value beetwen 1.28 and 1.72 USD per share, what Is wrong? I would assume 1.72 at least if not more... What if bod decides not to file for Dissolution but seeking a merger , there Is a small chance Dissolution cancelled and operations to resume. I find stock very cheap, a Shell with cash and equity without debt or positive equity around 25/30 mln
0 · Reply
dinnerwithme
dinnerwithme Feb. 6 at 4:47 AM
$BCAB $BCAB The company's strategy for maintaining its listing has never been successful. Fact check! 1. Maintain MVLS -> Failure (Nasdaq Disapproval) 2. BP partnership -> Failure (only inversagen AI deal) 3. bid compliance -> Failure (until 2/2) 4. PPA induces high stock conversion(11/26) -> failure, Yorkville maybe exit at Dec, Jan. 5. Issuance of Super Voting Rights -> Failure (Nasdaq Disapproval) 6. RS Strategy -> Failed twice 7. cash -> burning state 8. equity -> Only numbers are resolved through a joint venture from a company related to the representative(invergagen AI). deposit is unknown or secured) 9. Reverse merger -> ???? maybe f..... All that remains is liquidation or delisting. However, after liquidation, the cost for liquidation of creditors and executives and employees comes first. There is no shareholder's share. like $HOOK
0 · Reply
joe77w
joe77w Feb. 6 at 2:39 AM
$HOOK I would expect liquidation to happen at higher range around 1,71 USD given co.completed asset sale to GILEAD and now NEOTRAIL, its a matter of patience. I dont see any downside but only upside, strange pps does not hit 1,28 USD the minimum liquidation value. Holding tight my shares. Do your due diligence before investing your Money. This Is not a financial advice.
0 · Reply
joe77w
joe77w Feb. 6 at 2:34 AM
$HOOK new asset sale https://www.nasdaq.com/articles/hookipa-pharma-t0-sell-oncology-assets-hb-200-and-hb-700-neotrail-therapeutics
0 · Reply
joe77w
joe77w Feb. 6 at 12:11 AM
$HOOK new asset sale just happened, bullish view about liquidation value, 1,65 the minimum Just my opinion.
0 · Reply
pointnopoint
pointnopoint Feb. 5 at 10:17 PM
$HOOK Does this still hold up?
0 · Reply
biovaluable
biovaluable Feb. 4 at 12:44 PM
$BCAB will move like $HOOK which delisted last year.
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 3 at 1:32 PM
$HOOK ​​HOOK HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
0 · Reply
contrarianinme
contrarianinme Feb. 3 at 10:00 AM
$HOOK what is happening with this stock
0 · Reply
Popeye989
Popeye989 Oct. 14 at 3:16 PM
$HOOK another one bites the dust. So long from the watch list
0 · Reply
paulydestefano
paulydestefano Oct. 7 at 1:37 AM
If PRHI can crack above key resistance, it may go vertical. The fundamentals are aligned with technicals: micro float, oversold zone, and huge upside range. Add a short squeeze into the mix and you’ve got a textbook 20–50× candidate. $IBG $MODD $AVTX $YOSH $HOOK
0 · Reply
KobeSetups
KobeSetups Oct. 3 at 1:06 PM
If GIPR becomes the next REIT-crypto hybrid play, the re rate will be violent. Add in a micro float, real tenants, and a book value that’s completely ignored this could be the next legendary rerate ticker. Eyes on this before it headlines. $MNPR $THMO $LGVN $HOOK $PEV
0 · Reply
DataCenterTrader
DataCenterTrader Sep. 26 at 11:25 PM
IVDA is a rare find: ✔️ Robotics ✔️ AI ✔️ Drones ✔️ Undervalued ✔️ At the exact bottom This isn’t just a low float trade this is a tech sleeper with real-world potential. One volume spike or news cycle, and it could go vertical. $NAOV $COSM $HOOK $AVTX $SNMP
0 · Reply
KobeSetups
KobeSetups Sep. 7 at 8:34 PM
SKYQ is a deep sleeper with massive upside. 📈 Real revenue 🔋 Clean tech infrastructure 🧠 Blockchain expansion 🪙 Energy tokenization deal inked 💥 No dilution, low cap, and the chart is coiled This could wake up violently. $BFRG $HOOK $STSS $NAOV
0 · Reply
elmono
elmono Sep. 6 at 9:16 PM
$HOOK always right
0 · Reply